510(k) · Cleared
ClearedAngionew-IV
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Living Data Technologies Corporation · DRN Device, Counter-Pulsating, External
Cleared on Jan 30, 2003 as substantially equivalent to K940264 (Vasogenics, Inc., 1995) and 2 other predicates after an 87-day review. Its family tree reaches back 2 generations to 1995. 1 later device descends from it.
- Decided
- Jan 30, 2003
- Review
- 87 days
- Class
- Class II
- Product code
- DRN
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 2 generations to K940264 (1995). 4 ancestors in all. 1 later device descends from it, 1 citing it directly.
- Root · 2 generations backK940264 Vasogenics Eecp-MC2Vasogenics, Inc. · 1995
- 1 generation backK020857 Eecp Therapy System Model TS3 with Pulse Oximetry and Enhanced…Vasomedical, Inc. · 2002
- This deviceK023701 Angionew-IVLiving Data Technologies Corporation · 2003
- Descendant · cites it directly · 0 of its ownK033657 Mobile External Counter Pulsation System Angionew-VLiving Data Technologies Corporation · 2003
Most influential descendants
Showing 1 of 1 · See all- K033657Mobile External Counter Pulsation System Angionew-VLiving Data Technologies Corporation · 2003 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K940264 | Vasogenics Eecp-MC2 | Vasogenics, Inc. | 1995 | — |
| −1 | K020857 | Eecp Therapy System Model TS3 with Pulse Oximetry and Enhanced External… | Vasomedical, Inc. | 2002 | — |
| 0 (this device) | K023701 | Angionew-IV | Living Data Technologies Corporation | 2003 | — |
| +1 | K033657 | Mobile External Counter Pulsation System Angionew-V | Living Data Technologies Corporation | 2003 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2003 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DRN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DRN device
- #1 K250756 Pression Wave PRO External Counter-Pulsation…score 10.9 · 2 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K940264 | Vasogenics Eecp-MC2Summary page 1…Date Summary Prepared: October 31, 2002 2. Name of the Device: AngioNew-IV 3. Predicate Device Information: 1. Vasogenics, Inc., K#940264, Vasogenics EECP-MC2, Port Jefferson Station, NY. 2. Vasomedical, Inc., K020857, Enhanced External Counterpulsa… | 1995 |
| * | K020857 | Eecp Therapy System Model TS3 with Pulse Oximetry and Enhanced External Counterpulsation…Summary page 1…-IV 3. Predicate Device Information: 1. Vasogenics, Inc., K#940264, Vasogenics EECP-MC2, Port Jefferson Station, NY. 2. Vasomedical, Inc., K020857, Enhanced External Counterpulsation EECPBMC-2 External Counter Pulsating Device, Westbury, NY. 3. Beit Hapa'amo… | 2002 |
| * | K012141 | Aecp-a, Automatic External Counterpulsation DeviceSummary page 1…ulsation EECPBMC-2 External Counter Pulsating Device, Westbury, NY. 3. Beit Hapa'amon Automatic External Counterpulsating Device (AECP-A), K# 012141 , Kfar Saba, Israel. 4. Device Description: The Mobile External Counter Pulsation System AngioNew-IV is a mobile non… | 2001 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K033657 | Mobile External Counter Pulsation System Angionew-V | 2003 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 8 years and passes through 3 companies; a new generation was cleared every 7.3 years on median.
- None of the 4 ancestors has a recall.
- Of its descendants, K033657 (Living Data Technologies Corporation, 2003) has gone furthest, with 0 descendants of its own.
- 3 other devices also cite its predicate K940264.
How does its category compare?
All DRN devicesDRN Device, Counter-Pulsating, External: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · DRN
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · DRN
Too few DRN 510(k)s in any year since 2007 to give a median.
Recalls per year · DRN
1in 2009
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · DRN
1in 2024
MAUDE reports naming product code DRN, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 2 |
| 2008 | 1 | — | 0 | 0 |
| 2009 | 1 | — | 1 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 1 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 1 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 1 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 1 | — | 0 | 0 |
| 2019 | 1 | — | 0 | 0 |
| 2020 | 2 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 1 |
| 2025 | 1 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Mobile External Counter Pulsation System AngioNew-IV is a non-invasive external counter pulsation device intended for use in the treatment of patients with congestive heart failure, stable or unstable angina pectoris, acute myocardial infarction or cardiogenic shock.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K023701 · printed Nov 6, 2026
Cite this page
510(k) Report. “K023701: Angionew-IV.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K023701
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026